Previous 10 | Next 10 |
Search all articles related articles and news articles from the OTCMKTS NASDAQ and NYSE markets.
The Company maintains a disciplined capital structure and expects to demonstrate strong revenue growth, which makes it an exciting stock to watch out for.
The study presents a market analysis based on geographic regions, segmentation, and the financial results of important competitors.
The global athletic footwear market was valued at US$ 82.56 Billion in 2022 and is expected to expand at a CAGR of 4.8% during the forecast period, ranging from 2023 to 2033
The Company has attractive value propositions for franchisees and customers, which, along with an aggressive and effective growth strategy, help Xponential scale new heights.
The Company recently shared Q2 FY23 financial results, which showed continued revenue improvement and indicated a bright future.
Healthcare will soon be transformed through telemedicine, making it more inexpensive and available to individuals from all walks of life.
The Company was recently awarded a $29 million contract by the New York State Department of Transportation and continues to bag more and more lucrative projects from the government and commercial clients.
The Company has strong fundamentals, core markets in high-growth areas, and is doing much better than its industry peers.
The Company has strong fundamentals, core markets in high-growth areas, and is doing much better than its industry peers.
The Company has delivered robust revenue growth over the last five years, and we present our analysis on the road ahead.
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.03%Change Percent:
Pieris Pharmaceuticals Inc. Company Name:
PIRS Stock Symbol:
NASDAQ Market:
pieris.com Website: